Delivery Order SPE2DB22D2009-SPE2DB24FL8VP

Award Date 3/25/24
Potential Completion Date 3/26/24
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of RabAvert rabies vaccine with diluents. The fixed-price delivery order has a ceiling value of $1,930.30 and an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $6,949.08 firm-fixed-price delivery order is for RabAvert rabies vaccine with diluents. The award is not associated with a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of RabAvert rabies vaccine with diluents. The $2,095.80 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply RabAvert rabies vaccine with diluents. The contract, valued at $24,552.90, has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation indicated. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide RabAvert rabies vaccine with diluents. The contract is a firm fixed price delivery order with a ceiling value of $6,934.48 and a performance period through March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor and this order is part of a larger indefinite delivery contract (IDC) awarded by DLA...
This federal contract award is for the delivery of RabAvert rabies vaccine with diluents, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,033.42 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of RabAvert rabies vaccine with diluents. The $36,044.80 firm fixed-price delivery order is a part of a larger $999,999,999 Indefinite Delivery Contract between Amerisourcebergen and the DLA Troop Support Medical division, which serves as the primary vehicle for the company to supply a comprehensive range of pharmaceutical products...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract for $5,790.90 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply RabAvert rabies vaccine with diluents. This contract has a completion date of February 12, 2024 and is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and has previously received numerous federal contract awards from DLA to provide pharmaceuticals, medical supplies, and...
This federal contract award to Amerisourcebergen Drug Corp, a division of the major pharmaceutical distribution company Amerisourcebergen Corporation, is for the delivery of RABAVERT rabies vaccine with diluents. The $1,828.63 firm-fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical on June 26, 2024, with a completion date of June 27, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the supply of RabAvert Rabies Vaccine with Diluents under Delivery Order SPE2DB22D1002|SPE2DB24FLAV4. The contract has a firm fixed price of $1,158.18 and an ultimate completion date of April 17, 2024. The award was made by the Defense Logistics Agency (DLA), which is a defense agency responsible for providing logistics, acquisition, and technical services to the U.S. Armed Forces...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB24FL8VP
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of RabAvert rabies vaccine with diluents. The award, valued at $2,702.42, is a firm fixed price delivery order contract with a completion date of March 26, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used.

In addition to this specific award, Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. Amerisourcebergen also holds a separate indefinite delivery contract with the Department of Justice Federal Bureau of Investigation, valued up to $750,000 through May 2024, to provide medical supplies and prescription medications.

Generated 6/24/24, 9:41 AM